Mahdieh Abdi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mahdieh Abdi has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Behzad Baradaran
Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran
1 shared publication - Farid Mostafaei
Faculty of Pharmacy, Tabriz University of Medical Science, Tabriz, Iran
1 shared publication - Hadi Valizadeh
Tabriz University of Medical Sciences
1 shared publication - Muhammad Sarfraz
College of Pharmacy, Al Ain University, Al Ain P.O. Box 64141, United Arab Emirates
1 shared publication - Parvin Zakeri-Milani
Department of Pharmaceutics, Faculty of Pharmacy, Tabriz University of Medical Science, Tabriz, Iran
1 shared publication - Salar Hemmati
Tabriz University of Medical Sciences
1 shared publication
Latest Publications
- 1 October 2023
- Published by Taylor & Francis in Nanomedicine
- Vol. 18 (25) , 1855-1873
An Update Review of Smart Nanotherapeutics and Liver Cancer: Opportunities and Challenges
Hepatocellular carcinoma (HCC) is the most common form of primary liver cancer, typically diagnosed in advanced stages. Chemotherapy is necessary for treating advanced liver cancer; however, severa... Plain language summary Liver cancer is the third leading cause of cancer deaths in the world that is usually diagnosed in the last stages. Chemotherapy is commonly used to treat advanced liver canc... Graphical abstract
- 1 October 2023
- Published by Taylor & Francis in Nanomedicine
- Vol. 18 (25) , 1855-1873
An Update Review of Smart Nanotherapeutics and Liver Cancer: Opportunities and Challenges
Hepatocellular carcinoma (HCC) is the most common form of primary liver cancer, typically diagnosed in advanced stages. Chemotherapy is necessary for treating advanced liver cancer; however, severa... Plain language summary Liver cancer is the third leading cause of cancer deaths in the world that is usually diagnosed in the last stages. Chemotherapy is commonly used to treat advanced liver canc... Graphical abstract